- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
Precision medicine demands precision research. In other words, researchers require very specific human biospecimens to develop new techniques, tests, diagnostics, and treatments. Sadly, such samples are in sparse supply and finding them can be quite challenging and painful. Supply comes nowhere close to meeting demand. Genetic signatures are the quintessence of specificity in human biospecimens… The post Finally, an on-demand source of mutation characterized tumor FFPE tissue samples appeared first on iSpecimen.
When you need human biospecimens for research, we will help source them as quickly as possible. But here is a secret to getting them even earlier: contact us for help before you need your biospecimens. Well before. If you do, we will streamline the procurement process and develop a solid request for proposals (RFP) that… The post When planning a research project, strike before the iron is hot appeared first on iSpecimen.
Today is International Women's Day, a time to celebrate women's achievements and promote fairness and inclusion. And March is Women's History Month in the U.S., commemorating and encouraging the study, observance, and celebration of the vital role of women in American history. Tracy Curley, Chief Executive Officer and Chief Financial Officer At iSpecimen, we value… The post Appreciating women’s contributions to our mission appeared first on iSpecimen.
A Prime Catalyst for Evolving Biobanking Strategies Changes in the life sciences industry are creating challenges for biobanks, making their ability to evolve imperative to their success in the future. More specifically, the proliferation of precision medicine and regenerative medicine further underscores the need for highly customized biospecimen collections. Applications such as companion diagnostic development,… The post A data-driven journey to “just-in-time” biobanking appeared first on iSpecimen.
iSpecimen Marketplace® helps life science researchers in industry, government, and academia streamline the procurement of human biospecimens for their upstream research and work on treatments and diagnostics. The Marketplace also facilitates the sharing of specimens through our global network of biospecimen suppliers—including hospitals, labs, biobanks, and blood centers—by providing human biofluids, tissue, and cells for… The post Streamlining biospecimen sharing and sourcing appeared first on iSpecimen.
Plastics are ubiquitous in the developed world, and scientists have long known that humans breathe and inadvertently eat microscopic fragments – equivalent, by one account, to a credit card’s worth plastic every week. Now, for the first time, Dutch researchers have proved micro- and nanoplastic particles from the environment end up in the human bloodstream. It’s the latest discovery affirming the importance of human biospecimens in advancing medical progress. The post Plastic is everywhere, including our bloodstreams appeared first on iSpecimen.
Looks do matter, at least when it comes to immune system performance, suggests a new study. The post Beauty and immunity: natural bedfellows appeared first on iSpecimen.
Some of the best values are hidden in plain sight, like Toyotas, index funds and refurbished electronics. The same is true in the biospecimen world. Let us walk you through it. We’re known by many clients for giving researchers access to millions of banked and clinical remnant samples through our online platform, the iSpecimen Marketplace,… The post A case study in finding cost effective FFPE blocks appeared first on iSpecimen.
Why do roughly 1 in 3 COVID-19 patients experience symptoms lasting a month or more? And which newly diagnosed patients will develop so-called “long COVID”? Researchers may be approaching answers with the discovery that reduced levels of certain antibodies in the blood may help predict who will suffer long COVID. The post Soon, perhaps, a blood test for long COVID appeared first on iSpecimen.
As the pandemic continues to rear its ugly head this winter, we have strengthened our fight against the disease by expanding our supplier network with the addition of a new reference lab in New York to support commercial and government customers focused on COVID-19 research involving the Omicron and Delta variants. The reference lab has… The post iSpecimen expands fight against covid-19 appeared first on iSpecimen.